These results indicate that exposure to CAP-NR decreases the expression of neurodegenerative markers Tau pS396 and Aβ42, which play a crucial role in tauopathies and Alzheimer’s disease. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.